Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effect of Palm and LI4 (Hegu) Acupressure on Labor Pain, Labor Duration and Satisfaction

9 novembre 2026 mis à jour par: Emine Tekeli

The Effect of Palm and LI4 Acupressure Applications During Labor on Labor Pain, Duration and Satisfaction: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effects of palm (hand point) pressure and LI4 (Hegu) acupressure applied during labor on labor pain, duration of labor, and maternal birth satisfaction. A total of 105 nulliparous women aged 18-35 years with a term, low-risk, singleton pregnancy in spontaneous labor will be randomly assigned to three groups of 35: a palm pressure group, an LI4 acupressure group, and a control group receiving routine labor care. In the palm group, women press a wooden comb into their own palm during contractions. In the LI4 group, the researcher applies pressure to the LI4 point during contractions using an Electronic Acupuncture Pen and Meridian Massage Device. Applications are performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Pain is measured with a Visual Analog Scale and an observer-rated pain expression scale (ESVADOPA) before and 30 minutes after each application. Duration of labor and neonatal Apgar scores are recorded, and birth satisfaction is assessed within 4 hours after birth. The study is conducted in a single center in Gaziantep, Türkiye.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

105

Phase

  • N'est pas applicable

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 35 ans (Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Femelle

La description

Inclusion Criteria:

  • Aged 18-35 years
  • Able to read, write and understand Turkish
  • Nulliparous woman with a term pregnancy (37-42 weeks of gestation)
  • Singleton, live fetus in vertex presentation
  • Spontaneous onset of labor
  • Cervical dilatation of 4 cm or more
  • Estimated fetal weight of 2500-4000 g confirmed by ultrasound by a physician
  • No risk factors in obstetric and medical history (low-risk pregnancy)
  • Willing to participate and gives written informed consent

Exclusion Criteria:

  • Multiple pregnancy
  • Pregnancy achieved by in vitro fertilization (IVF)
  • Complicated pregnancy (e.g., gestational diabetes, hypertensive disorders)
  • Previous cesarean delivery
  • Presentation anomaly
  • Induction of labor
  • Neurological, psychiatric or communication-impairing disease
  • Use of, or planned use of, another pain-relief method (e.g., hot/cold application, TENS, aromatherapy, massage)
  • Structural or chromosomal fetal anomaly
  • Obesity according to the World Health Organization classification (BMI 30 kg/m2 or higher)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Palm Pressure Group

Women apply pressure with a curved wooden comb to their own palm (Lao Gong point) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, under the supervision of the researcher. Routine labor care continues.

Palm Pressure Group:

A curved wooden comb is pressed by the woman into her own palm (Lao Gong point) during contractions. After the researcher demonstrates the technique, pressure is applied for six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

Autres noms:
  • Hand point comb
  • LI4 pressure
Expérimental: LI4 Acupressure Group

The researcher locates the LI4 (Hegu) point with an Electronic Acupuncture Pen and Meridian Massage Device and applies pressure (about 3-5 kg of force) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Routine labor care continues.

The researcher locates the LI4 (Hegu) point on the back of the hand with an Electronic Acupuncture Pen and Meridian Massage Device, which signals the point by light and sound. Pressure (about 3-5 kg of force) is then applied with the device. The application is performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

Aucune intervention: Control Group

Women receive routine midwifery care in the delivery room with no additional intervention. Pain measurements are made at the same dilatation stages as in the other groups.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Labor pain intensity measured by Visual Analog Scale (VAS)
Délai: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

Women rate the pain felt after a contraction on a vertical Visual Analog Scale from 0 (no pain) to 10 (severe pain). The mark is measured with a ruler and recorded as the pain score. Higher scores indicate more pain.

Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Pain expression measured by the Rating Scale of Pain Expression during Childbirth (ESVADOPA)
Délai: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

An independent observer who is unaware of group allocation rates pain expression during contractions with ESVADOPA. The scale has 6 items (facial muscles, body response, verbal response, restlessness, ability to relax, vegetative symptoms), each scored 0-3. Total scores range from 0 to 18; higher scores indicate more pain expression.

Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor
Duration of labor
Délai: From admission to the delivery room until delivery of the placenta (during labor and birth)

Duration of labor stages calculated in minutes from times recorded on the labor follow-up form: admission to the delivery room, start and end of the second stage, and delivery of the placenta.

From admission to the delivery room until delivery of the placenta (during labor and birth)
Birth satisfaction measured by the Birth Satisfaction Scale
Délai: Within 4 hours after birth

Women complete the 10-item Birth Satisfaction Scale (Turkish version), rated on a 5-point Likert scale (0-4), with reverse scoring for 4 items. Total scores range from 0 to 40; higher scores indicate greater birth satisfaction.

Within 4 hours after birth
Neonatal Apgar score
Délai: 1 minute and 5 minutes after birth

Apgar scores of the newborn, recorded on the labor follow-up form. Scores range from 0 to 10; higher scores indicate a better condition of the newborn.

1 minute and 5 minutes after birth

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

13 novembre 2026

Achèvement primaire (Estimé)

28 février 2027

Achèvement de l'étude (Estimé)

30 mars 2027

Dates d'inscription aux études

Première soumission

9 novembre 2026

Première soumission répondant aux critères de contrôle qualité

9 novembre 2026

Première publication (Réel)

16 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

16 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

9 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2026/64

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner